EDGAR Filing Documents for 0001410578-24-001685

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001410578-24-001685

Filing Date

2024-10-21

Accepted

2024-10-21 07:31:25

Documents

Period of Report

2024-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	tmb-20240630x10q.htm iXBRL	10-Q	2004713
2	EX-3.1	tmb-20240630xex3d1.htm	EX-3.1	899939
3	EX-31.1	tmb-20240630xex31d1.htm	EX-31.1	11885
4	EX-31.2	tmb-20240630xex31d2.htm	EX-31.2	11888
5	EX-32.1	tmb-20240630xex32d1.htm	EX-32.1	7390
6	GRAPHIC	tmb-20240630xex3d1001.jpg	GRAPHIC	5071
7	GRAPHIC	tmb-20240630xex3d1002.jpg	GRAPHIC	5178
	Complete submission text file	0001410578-24-001685.txt		10817402

Data Files

Seq	Description	Document	Type	Size
8	EX-101.SCH	tmb-20240630.xsd	EX-101.SCH	80093
9	EX-101.CAL	tmb-20240630_cal.xml	EX-101.CAL	66599
10	EX-101.DEF	tmb-20240630_def.xml	EX-101.DEF	349699
11	EX-101.LAB	tmb-20240630_lab.xml	EX-101.LAB	697395
12	EX-101.PRE	tmb-20240630_pre.xml	EX-101.PRE	527964
95	EXTRACTED XBRL INSTANCE DOCUMENT	tmb-20240630x10q_htm.xml	XML	1621129

Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431

Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020

Entero Therapeutics, Inc. (Filer) CIK: 0001604191 (see all company filings)